Advanced search
Publication Cover
Cancer Biology & Therapy Volume 14, 2013 - Issue 7
Submit an article Journal homepage
943
Views
27
CrossRef citations to date
0
Altmetric
Research Paper

Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells

Namita Chatterjee Cancer Research Center; Department of Biomedical Sciences; School of Public Health; University at Albany; Rensselaer, NY USA
,
Wei-Lin Winnie Wang Cancer Research Center; Department of Biomedical Sciences; School of Public Health; University at Albany; Rensselaer, NY USA
,
Tucker Conklin Cancer Research Center; Department of Biomedical Sciences; School of Public Health; University at Albany; Rensselaer, NY USA
,
Sridar Chittur Cancer Research Center; Department of Biomedical Sciences; School of Public Health; University at Albany; Rensselaer, NY USA
&
Martin Tenniswood Cancer Research Center; Department of Biomedical Sciences; School of Public Health; University at Albany; Rensselaer, NY USACorrespondence[email protected]
Pages 658-671 | Received 07 Feb 2013, Accepted 19 May 2013, Published online: 24 Jun 2013

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Esma Alp, Fehmi Damkaci, Eylem Guven & Martin Tenniswood. (2019) Starch nanoparticles for delivery of the histone deacetylase inhibitor CG-1521 in breast cancer treatment. International Journal of Nanomedicine 14, pages 1335-1346.
Read now
Stefan Swierczynski, Eckhard Klieser, Romana Illig, Beate Alinger-Scharinger, Tobias Kiesslich & Daniel Neureiter. (2015) Histone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases. Expert Opinion on Biological Therapy 15:5, pages 651-664.
Read now

Articles from other publishers (25)

Brittany L. Witt & Trygve O. Tollefsbol. (2023) Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research. Life 13:12, pages 2311.
Crossref
Christian Bailly. (2023) Discovery and Anticancer Activity of the Plagiochilins from the Liverwort Genus Plagiochila. Life 13:3, pages 758.
Crossref
Zonglong Hu, Fan Wei, Yi Su, Yafang Wang, Yanyan Shen, Yanfen Fang, Jian Ding & Yi Chen. (2023) Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression. Signal Transduction and Targeted Therapy 8:1.
Crossref
Siddhartha Das Pramanik, Amit Kumar Halder, Ushmita Mukherjee, Dharmendra Kumar, Yadu Nandan Dey & Mogana R. (2022) Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer. Frontiers in Chemistry 10.
Crossref
Flavia Lima Costa Faldoni, Cláudia Aparecida Rainho & Silvia Regina Rogatto. (2020) Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives. Cells 9:5, pages 1164.
Crossref
Meran Keshawa Ediriweera & Somi Kim Cho. (2020) Targeting miRNAs by histone deacetylase inhibitors (HDACi): Rationalizing epigenetics-based therapies for breast cancer. Pharmacology & Therapeutics 206, pages 107437.
Crossref
Meran Keshawa Ediriweera, Kamani Hemamala Tennekoon & Sameera Ranganath Samarakoon. (2019) Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents. Drug Discovery Today 24:3, pages 685-702.
Crossref
Pingping Guo, Wenqi Chen, Huiyu Li, Meiying Li & Lisha Li. (2018) The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications. Pathology & Oncology Research 24:4, pages 807-813.
Crossref
Oliver Zierau, Janina Helle, Sabina Schadyew, Yanni Morgenroth, Martin Bentler, Alexander Hennig, Sridar Chittur, Martin Tenniswood & Georg Kretzschmar. (2018) Role of miR‐203 in estrogen receptor‐mediated signaling in the rat uterus and endometrial carcinoma. Journal of Cellular Biochemistry 119:7, pages 5359-5372.
Crossref
Ping He, Ke Li, Shi-Bao Li, Ting-Ting Hu, Ming Guan, Fen-Yong Sun & Wei-Wei Liu. (2018) Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer. International Journal of Oncology.
Crossref
Azusa Tanimoto, Shinji Takeuchi, Sachiko Arai, Koji Fukuda, Tadaaki Yamada, Xavier Roca, S. Tiong Ong & Seiji Yano. (2017) Histone Deacetylase 3 Inhibition Overcomes BIM Deletion Polymorphism–Mediated Osimertinib Resistance in EGFR- Mutant Lung Cancer . Clinical Cancer Research 23:12, pages 3139-3149.
Crossref
Ricardo Costa, Cesar A. Santa-Maria, Giovanna Rossi, Benedito A. Carneiro, Young Kwang Chae, William J. Gradishar, Francis J. Giles & Massimo Cristofanilli. (2016) Developmental therapeutics for inflammatory breast cancer: Biology and translational directions. Oncotarget 8:7, pages 12417-12432.
Crossref
Jan Baumann, Jason Wong, Yan Sun & Douglas S. Conklin. (2016) Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells. BMC Cancer 16:1.
Crossref
Xueli Pang, Gang He, Chao Luo, Yan Wang & Bo Zhang. (2015) Knockdown of Rad9A enhanced DNA damage induced by trichostatin A in esophageal cancer cells. Tumor Biology 37:1, pages 963-970.
Crossref
J. Diessner, R. Van Ewijk, C. R. Weiss, W. Janni, M. B. Wischnewsky, R. Kreienberg, K. Hancke, M. Blettner, A. Wöckel & L. Schwentner. (2015) Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study. Archives of Gynecology and Obstetrics 292:3, pages 655-664.
Crossref
Ann-Christin Gaupel, Thomas J. Begley & Martin Tenniswood. (2015) Gcn5 Modulates the Cellular Response to Oxidative Stress and Histone Deacetylase Inhibition. Journal of Cellular Biochemistry 116:9, pages 1982-1992.
Crossref
Saira R. Ali, Karen J. Humphreys, Ross A. McKinnon & Michael Z. Michael. (2015) Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review. Drug Development Research 76:6, pages 296-317.
Crossref
Kimiko Inoue, Mami Oikawa, Satoshi Kamimura, Narumi Ogonuki, Toshinobu Nakamura, Toru Nakano, Kuniya Abe & Atsuo Ogura. (2015) Trichostatin A specifically improves the aberrant expression of transcription factor genes in embryos produced by somatic cell nuclear transfer. Scientific Reports 5:1.
Crossref
Joon-Ho Cho, Manjari Dimri & Goberdhan P. Dimri. (2015) MicroRNA-31 Is a Transcriptional Target of Histone Deacetylase Inhibitors and a Regulator of Cellular Senescence. Journal of Biological Chemistry 290:16, pages 10555-10567.
Crossref
Namita Chatterjee & Martin Tenniswood. (2015) The potential of histone deacetylase inhibitors in breast cancer therapy. Breast Cancer Management 4:2, pages 85-97.
Crossref
Ammad A. Farooqi, Muhammad Z. Qureshi & Muhammad Ismail. 2015. Personalized Epigenetics. Personalized Epigenetics 461 474 .
Ann-Christin Gaupel, Thomas Begley & Martin Tenniswood. (2014) High throughput screening identifies modulators of histone deacetylase inhibitors. BMC Genomics 15:1.
Crossref
Tiffany Avery & Massimo Cristofanilli. (2014) Biomarkers and Therapeutic Targets in Inflammatory Breast Cancer (IBC). Current Breast Cancer Reports 6:4, pages 245-250.
Crossref
Madhusudhanan Narasimhan, Amanjot Kaur Riar, Mary Latha Rathinam, Dhanashree Vedpathak, George Henderson & Lenin Mahimainathan. (2014) Hydrogen peroxide responsive miR153 targets Nrf2/ARE cytoprotection in paraquat induced dopaminergic neurotoxicity. Toxicology Letters 228:3, pages 179-191.
Crossref
ALAN LAP-YIN PANG, ALEXANDRA C. TITLE & OWEN M. RENNERT. (2014) Modulation of microRNA expression in human lung cancer cells by the G9a histone methyltransferase inhibitor BIX01294. Oncology Letters 7:6, pages 1819-1825.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.